IP Library Granted Patent US 10,030,249
Granted Patent B2
US 10,030,249 · App. 14/852,158 · Granted Jul 24, 2018

Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,249
App. No.
14/852,158
Granted
Jul 24, 2018
Kind
B2
Abstract

Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.

Claims (17)

1. A method for increasing a nicotinic alkaloid in a Nicotiana plant, comprising up-regulating a transcription factor that positively regulates nicotinic alkaloid biosynthesis, wherein the transcription factor is up-regulated by:

(a) introducing into the Nicotiana plant an expression construct comprising a nucleic acid molecule selected from the group consisting of:

(i) the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2;

(ii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 3; and

(iii) a nucleotide sequence that is at least 90% identical to the nucleotide sequences of (i) or (ii), and which encodes a transcription factor that positively regulates nicotinic alkaloid biosynthesis; and

(b) growing the Nicotiana plant under conditions whereby the expression construct increases levels of the transcription factor in the Nicotiana plant as compared to a control Nicotiana plant grown under similar conditions;

wherein the nucleic acid molecule is operably linked to one or more heterologous control sequences suitable for directing expression in a Nicotiana plant.

2. The method of claim 1 , further comprising overexpressing at least one additional transcription factor that positively regulates nicotinic alkaloid biosynthesis.

3. The method of claim 2 , further comprising suppressing the expression of at least one transcription factor that negatively regulates nicotinic alkaloid biosynthesis.

4. A genetically engineered nicotinic alkaloid-producing Nicotiana plant produced by the method of claim 2 , wherein the plant comprises a chimeric nucleic acid construct comprising a nucleic acid molecule encoded by a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2;

(b) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 3; and

(c) a nucleotide sequence at least 90% identical to the nucleotide sequences of (a) or (b), and which encodes a transcription factor that positively regulates nicotinic alkaloid biosynthesis;

wherein the nucleic acid molecule is linked to a heterologous nucleic acid to form a chimeric nucleic acid construct.

5. The engineered Nicotiana plant of claim 4 , wherein the plant is a Nicotiana tabacum plant.

6. Seeds from the engineered Nicotiana plant of claim 4 , wherein the seeds comprise the chimeric nucleic acid construct.

7. A product comprising the engineered Nicotiana plant of claim 4 , wherein the product has an increased level of nicotinic alkaloid relative to a product produced from a non-transformed control Nicotiana plant.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055660/0188 →